| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.06 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.06 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.06 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.085 | 0.06 |
| mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.06 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.071 | 0.06 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.07 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | 0.062 | 0.07 |
| mRNA | 16-beta-bromoandrosterone | CTRPv2 | pan-cancer | AAC | 0.074 | 0.07 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | 0.062 | 0.07 |